Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 9:9:880796.
doi: 10.3389/fmed.2022.880796. eCollection 2022.

Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients

Affiliations

Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients

Gilberto Marcelo Sperandio da Silva et al. Front Med (Lausanne). .

Erratum in

  • Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients.
    Sperandio da Silva GM, Mediano MFF, Murgel MF, Andrade PM, de Holanda MT, da Costa AR, Veloso HH, Carneiro FM, Valete Rosalino CM, de Sousa AS, Mendes FSNS, Pinheiro RO, Veloso VG, Saraiva RM, Hasslocher-Moreno AM. Sperandio da Silva GM, et al. Front Med (Lausanne). 2022 Jul 26;9:963805. doi: 10.3389/fmed.2022.963805. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35957851 Free PMC article.

Abstract

The COVID-19 virus infection caused by the new SARS-CoV-2 was first identified in Rio de Janeiro (RJ), Brazil, in March 2020. Until the end of 2021, 504,399 COVID-19 cases were confirmed in RJ, and the total death toll reached 68,347. The Evandro Chagas National Institute of Infectious Diseases from Oswaldo Cruz Foundation (INI-Fiocruz) is a referral center for treatment and research of several infectious diseases, including COVID-19 and Chagas disease (CD). The present study aimed to evaluate the impact of COVID-19 on in-hospital mortality of patients with CD during the COVID-19 pandemic period. This observational, retrospective, longitudinal study evaluated all patients with CD hospitalized at INI-Fiocruz from May 1, 2020, to November 30, 2021. One hundred ten hospitalizations from 81 patients with CD (58% women; 68 ± 11 years) were evaluated. Death was the study's main outcome, which occurred in 20 cases. The mixed-effects logistic regression was performed with the following variables to test whether patients admitted to the hospital with a COVID-19 diagnosis would be more likely to die than those admitted with other diagnoses: admission diagnosis, sex, age, COVID-19 vaccination status, CD clinical classification, and the number of comorbidities. Results from multiple logistic regression analysis showed a higher risk of in-hospital mortality in patients diagnosed with COVID-19 (OR 6.37; 95% CI 1.78-22.86) compared to other causes of admissions. In conclusion, COVID-19 infection had a significant impact on the mortality risk of INI-Fiocruz CD patients, accounting for one-third of deaths overall. COVID-19 presented the highest percentage of death significantly higher than those admitted due to other causes during the COVID-19 pandemic.

Keywords: COVID-19; Chagas disease; SARS-CoV-2; Trypanosoma cruzi; in-hospital mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Saraiva RM, Mediano MFF, Mendes FS, Sperandio da Silva GM, Veloso HH, Sangenis LHC, et al. . Chagas heart disease: an overview of diagnosis, manifestations, treatment, and care. World J Cardiol. (2021) 13:654–75. 10.4330/wjc.v13.i12.654 - DOI - PMC - PubMed
    1. World Health Organization . Global Distribution of Cases of Chagas Disease Based on Official Estimates, 2018. World Health Organization (2018). Available online at: https://www.who.int/docs/default-source/ntds/chagas-disease/chagas-2018-... (accessed April 13, 2022).
    1. Dias JCP, Ramos AN Jr, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. . 2nd Brazilian Consensus on Chagas Disease, 2015. Rev Soc Bras Med Trop. (2016) 49:3–60. 10.1590/0037-8682-0505-2016 - DOI - PubMed
    1. World Health Organization (WHO) . Archived: WHO Timeline - COVID-19. (2020). Available online at: https://www.who.int/news/item/27-04-2020-who-timeline—covid-19 (accessed January 29, 2022).
    1. Ministerio da Saúde do Brasil . Painel Coronavírus. (2022). Available online at: https://covid.saude.gov.br/ (accessed January 28, 2022).